Grants per year
Personal profile
Research Interests
Daniel Batlle MD is the Earle, del Greco, Levin Professor of Medicine at Northwestern University. He has been a Professor of Medicine at Northwestern and past Division Chief for 18 years . His clinical and research interests include acid-base disturbances, electrolyte disorders, hypertension, and diabetic nephropathy. Bench research currently involves the study of the renin angiotensin system and enzymes that degrade angiotensin 2 such as ACE2 and its potential therapeutic use.
Certifications and Licenses
| Internal Medicine | |
| Nephrology |
Training Experience
| 1976 | Internship, Saint John Hospital and Medical Center, Detroit, Michigan |
| 1977 | Residency, Wayne State University |
| 1979 | Fellowship, Univ. of Illinois Hospital |
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
MD, University of Barcelona
… → 1973
Research interests
- Hypertension
- Kidney
- Nephrology
Fingerprint
Dive into the research topics where Daniel Batlle is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Novel Short ACE2 variant for Delayed Graft Function
Batlle, D., Ansari, M. J. I., Wysocki, J. & Zhang, Z. J.
National Institute of Allergy and Infectious Diseases
11/1/21 → 10/31/23
Project: Research project
-
NCR-19-2039- Ammonium excretion in ZS-9 treated mice with CKD
AstraZeneca Pharmaceuticals LP
5/26/20 → 10/31/22
Project: Research project
-
The Role of MicroRNAs in Corneal Epithelial Homeostasis
Lavker, R. M., Batlle, D., Peng, H. & Thaxton, C. S.
7/1/19 → 7/31/23
Project: Research project
-
Prot #16244: A Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Multicenter, Event-Driven Phase III Study to Investigate the Efficacy and Safety of Finerenone, in Addition to Standard of Care, on the Progression of Kidney Disease in Subjects
Huang, W., Batlle, D., Wallia, A. & Molitch, M. E.
Bayer HealthCare Pharmaceuticals, Inc.
1/5/16 → 5/31/20
Project: Research project
-
A Novel Soluble ACE2 Protein Provides Lung and Kidney Protection in Mice Susceptible to Lethal SARS-CoV-2 Infection
Hassler, L., Wysocki, J., Gelarden, I., Sharma, I., Tomatsidou, A., Ye, M., Gula, H., Nicoleascu, V., Randall, G., Pshenychnyi, S., Khurram, N., Kanwar, Y., Missiakas, D., Henkin, J., Yeldandi, A. & Batlle, D., Jul 2022, In: Journal of the American Society of Nephrology. 33, 7Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations -
Circulating ACE2-expressing extracellular vesicles block broad strains of SARS-CoV-2
El-Shennawy, L., Hoffmann, A. D., Dashzeveg, N. K., McAndrews, K. M., Mehl, P. J., Cornish, D., Yu, Z., Tokars, V. L., Nicolaescu, V., Tomatsidou, A., Mao, C., Felicelli, C. J., Tsai, C. F., Ostiguin, C., Jia, Y., Li, L., Furlong, K., Wysocki, J., Luo, X., Ruivo, C. F., & 16 others, Dec 2022, In: Nature communications. 13, 1, 405.Research output: Contribution to journal › Article › peer-review
Open Access12 Scopus citations -
Effect of Sodium Zirconium Cyclosilicate on Serum Potassium and Bicarbonate in Patients with Hyperkalemia and Metabolic Acidosis Associated with Chronic Kidney Disease: Rationale and Design of the NEUTRALIZE Study
Ash, S. R., Batlle, D., Kendrick, J., Oluwatosin, Y., Pottorf, W., Brahmbhatt, Y., Guerrieri, E. & Fried, L., 2022, (Accepted/In press) In: Nephron.Research output: Contribution to journal › Article › peer-review
Open Access -
Evidence in favor of the essentiality of human cell membrane-bound ACE2 and against soluble ACE2 for SARS-CoV-2 infectivity
Batlle, D., Monteil, V., Garreta, E., Hassler, L., Wysocki, J., Chandar, V., Schwartz, R. E., Mirazimi, A., Montserrat, N., Bader, M. & Penninger, J. M., May 26 2022, In: Cell. 185, 11, p. 1837-1839 3 p.Research output: Contribution to journal › Letter › peer-review
Open Access2 Scopus citations -
Kidney Angiotensin in Cardiovascular Disease: Formation and Drug Targeting
Lin, H., Geurts, F., Hassler, L., Batlle, D., Colafella, K. M. M., Denton, K. M., Zhuo, J. L., Li, X. C., Ramkumar, N., Koizumi, M., Matsusaka, T., Nishiyama, A., Hoogduijn, M. J., Hoorn, E. J. & Danser, A. H. J., Jul 1 2022, In: Pharmacological Reviews. 74, 3, p. 462-505 44 p.Research output: Contribution to journal › Review article › peer-review
Open Access1 Scopus citations